The commission proposes to ease some regulations on simulcasting but stops short of setting a timeline for ATSC 1.0 phase-out ...
Preclinical data with TK-6302 has shown best-in-class anti-tumor efficacy, demonstrating its potential to elicit deep and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback